Loading…
Indication added
| conditions | Small Cell Lung Carcinoma,Large Cell Neuroendocrine Carcinoma of the Lung,Neuroendocrine Prostate Cancer,Gastroenteropancreatic Neuroendocrine Carcinoma | → | Small Cell Lung Carcinoma,Large Cell Neuroendocrine Carcinoma of the Lung,Neuroendocrine Prostate Cancer,Gastroenteropancreatic Neuroendocrine Carcinoma,Non-prostate Extrapulmonary Neuroendocrine Carcinoma,Cervical Neuroendocrine Carcinoma,Thymic Neuroendocrine Carcinoma,Genitourinary Neuroendocrine Carcinoma,Unknown Primary Neuroendocrine Carcinomas,Merkel Cell Carcinoma,Medullary Thyroid Carcinoma |
Seven dimensions, unsigned magnitude 0–100. Direction is resolved separately, per entity, because one event is good for one name and bad for another.
No other named entities identified.This event has no scored competitor read-through.
No real valuation-relevant phase transition on a resolved asset for this event.This section fires only when the event carries a resolved asset and a real phase change — not guessed for every event.